IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025
Provided By PR Newswire
Last update: Jul 3, 2025
CAESAREA, Israel, July 3, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced preliminary financial results as of and for the three and six months ended June 30, 2025.
Read more at prnewswire.com
